Bart De Taeye is a seasoned professional with extensive experience in drug discovery and investment management. They served as a Research Assistant Professor at Northwestern University and held research positions at Vanderbilt University and reMYND NV. From 2014 to 2018, they led search and evaluation efforts at CISTIM and have since taken on leadership roles, including as an Investment Director at PMV and a member of the board for various therapeutic companies. Bart currently holds positions on the board of directors for AstriVax and Augustine Therapeutics, among others, while continuing to contribute to the life sciences field.
This person is not in the org chart
This person is not in any teams
This person is not in any offices